Navigation Links
New President and CEO appointed at Ocean Nutrition Canada Limited

DARTMOUTH, NS, July 6 /PRNewswire/ - Ocean Nutrition Canada Limited - Long time Ocean Nutrition Canada Ltd. (ONC) President and CEO, Robert Orr, will make way for a new CEO to lead the company's next growth phase, with particular focus on international expansion efforts and the food sector.

Martin Jamieson, a 30 year international food industry veteran, has been appointed as the new President and CEO at ONC. He will oversee day-to-day operations at the Dartmouth, Nova Scotia-based Omega-3 dietary supplement and food ingredient, researcher and manufacturer.

Orr, company co-founder with John Risley, becomes Chairman, who will work with Jamieson and the Board of Directors in charting the firm's strategic direction and will focus on Omega-3 category growth activities.

Martin Jamieson has an impressive background growing firms with familiar household names. Most recently, Jamieson was Executive Vice President of Loblaw Brands at Loblaw Companies, Canada's leading food retailer, responsible for the management and marketing of their $7 billion private label business. Prior to that, he was President of Robin Hood Multifoods and before that President of Pillsbury Canada Ltd.

Jamieson came to Canada with Pillsbury, after successfully running the firm's UK/Ireland business. Additionally, he led pan-European marketing and strategic planning for Häagen-Dazs and spearheaded the brand's introduction and growth across 14 countries.

In addition to his brand marketing skills, international food industry experience and strong leadership track record, Jamieson also brings a strong technical knowledge to his new position. Jamieson studied food technology at Cheshire College of Agriculture in the UK and began his career as a food processor and food technologist, in the dairy industry. He also holds a BSc (hons) in Food Marketing Management from Sheffield Hallam University in the U.K.

"Talent, particularly leadership talent, is the key to sustaining growth and profitability in our industry. Building an internationally competitive company with sustainable differentiation requires a particular skill set. Martin has that talent and skill set. We are very fortunate to have him joining ONC and accepting the challenge of taking the company to the next level" said Orr.

"I am delighted to be joining Ocean Nutrition Canada as President and CEO of this remarkable company. The company is a leader in its field, is growing rapidly internationally and employs some of the most passionate and talented people that I have met in over 30 years in the international food industry. I look forward to leading the company through the next phase of rapid growth and development" Jamieson said.

ONC is the leading provider of Omega 3, EPA & DHA, ingredients to the dietary supplement and food industry, with operations in Nova Scotia, Wisconsin and Peru and sales offices in Canada, USA, Europe, Australia and China and has over 300 employees.

About Ocean Nutrition Canada Limited (ONC):

Ocean Nutrition Canada is a privately held company, whose major shareholder is Clearwater Fine Foods Incorporated. Clearwater Fine Foods Incorporated is a diversified holding/investment company whose significant holdings include a controlling interest in Clearwater Seafood's Limited Partnership, the world's largest integrated shellfish harvester and processor.

ONC is the world's largest supplier of Omega-3 EPA and DHA ingredients from fish oil, marketed into the dietary supplement and food manufacturing markets. To date MEG-3(R) ingredients have been included in over 82 billion servings of food and supplement products world wide. For more information on the health benefits of MEG-3(R) ingredients please visit

SOURCE Ocean Nutrition Canada Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
5. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
6. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
7. CryoLife Names Philip Theodore as Vice President, General Counsel
8. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
9. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
(Date:11/24/2015)... Switzerland (PRWEB) , ... November 24, 2015 , ... ... plant and the environment are paramount. Insertion points for in-line sensors can represent ... has developed the InTrac 781/784 series of retractable sensor housings , which ...
(Date:11/24/2015)... , Nov. 24, 2015 HemoShear ... on discovering drugs for metabolic disorders, announced today ... to its Board of Directors (BOD). Mr. Watkins ... of Human Genome Sciences (HGS), and also served ... Jim Powers , Chairman and CEO ...
(Date:11/23/2015)... , Nov. 24, 2015 Women with a ... CT exams face a higher risk of lung cancer than ... presented next week at the annual meeting of the Radiological ... --> --> Lung nodules ... classified as solid or subsolid based on their appearance on ...
(Date:11/23/2015)... The royalty-free a greement a llows ... 112 low- and m iddle-i ncome ... --> The Medicines Patent Pool (MPP) today announced its ... with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that ... virus.  The royalty-free licence will enable generic manufacture of daclatasvir ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
Breaking Biology News(10 mins):